Discover a study that found that the combination of durvalumab and tremelimumab with concurrent radiotherapy is a feasible ...

The Old Rectory Darts Team's Kevin Green passed away from terminal bladder cancer last year, but the team honoured his idea ...

When facing a diagnosis or suspicious tumor related to urologic cancers, such as prostate, kidney, or bladder cancer, it can ...

The following is a summary of "Senescence-specific molecular subtypes stratify the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer," published in the February ...

Pat Patterson is a true pro wrestling legend who completely changed the game. Here are some interesting facts about the WWE ...

A new generation of therapeutics looks beyond simply reengineering the gut microbiome to exploiting multiple pathways for novel microbiome and microbial applications.

The US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for Anktiva ...

Reports Q4 revenue $7.55M, consensus $9.51M. “The first quarter of 2025 has been an inflection point for the Company with multiple milestones ...

Join the University of Exeter's £6.5m project to help the NHS achieve net-zero carbon emissions by 2045, developing tools to ...

Handelsbanken Fonder AB purchased a new position in shares of CG Oncology, Inc. (NASDAQ:CGON – Free Report) in the fourth quarter, HoldingsChannel.com reports. The firm purchased 13,300 shares of the ...

AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been recommended for approval in the European Union (EU) for the treatment of adults with resectable non-small cell lung cancer ...